Knowledge Library Prototype
Cardiology Intelligence
Prototype collection covering cardiovascular therapeutics, hypertension, heart failure, lipid management, anticoagulation, diabetes-related cardiovascular risk, FDA updates, clinical trials, and AJPPS research.
Featured AJPPS Research
Placeholder for AJPPS cardiovascular, hypertension, pharmacotherapy, and outcomes research.
Latest Cardiology Intelligence
Reserved for approved RSS/API content relevant to pharmacists, pharmaceutical scientists, clinicians, educators, and students.
FDA & Regulatory Updates
- BsUFA IV: Fiscal Years 2028-2032
by FDA on 07/16/2026 at 5:00 pmOn September 30, 2022, the President signed into law the FDA User Fee Reauthorization Act of 2022.
- MantroForce - 729021 - 06/17/2026by FDA on 07/16/2026 at 4:35 pm
Unapproved New Drugs/Misbranded
- CDER Small Business & Industry Assistance (SBIA)by FDA on 07/16/2026 at 4:34 pm
A Comprehensive Resource for Information on Human Drug Development in Regulation
- Wholesale Peptide - 729447 - 06/17/2026by FDA on 07/16/2026 at 4:22 pm
Unapproved New Drugs/Misbranded
- Texinkart Inc. - 729046 - 06/17/2026by FDA on 07/16/2026 at 4:20 pm
Unapproved New Drugs/Misbranded
Clinical Trials Watch
Future ClinicalTrials.gov integration for hypertension, heart failure, lipid disorders, anticoagulation, and cardiometabolic disease.
Clinical Practice & Therapeutics
Future summaries should connect evidence updates to pharmacy practice, medication safety, guideline changes, and patient counseling.
Related Collections
- Diabetes & Cardiometabolic Intelligence
- FDA Approvals & Medication Safety
- Pharmacogenomics Intelligence